225
Participants
Start Date
November 21, 2018
Primary Completion Date
July 12, 2019
Study Completion Date
July 12, 2019
Paliperidone Palmitate 3-Month Formulation (PP3M)
No intervention will be administered as a part of this study. Participants who have been treated with PP3M in clinical practice will be enrolled.
Hosp. Psiquiatrico Alava, Vitoria-Gasteiz
Chu Brugmann, Brussels
Toldy Ferenc Kórház-Rendelőintézet, Cegléd
CSM Frosinone, Frosinone
Hosp. Univ. de Torrevieja, Torrevieja
Sántha Kálmán Szakkórház, Nagykálló
Centre Medico Psychologique Le Rembrandt, Nice
Centre Medico Psychologique, Cagnes-sur-Mer
Tolna Megyei Balassa Janos Korhaz, Szekszárd
Corporacio Sanitari Parc Tauli, Sabadell
Centre Hosp. de Manresa, Manresa
Kemenesaljai Egyesített Kórház-Szakorvosi Rendelointézet, Celldömölk
Vivantes Klinikum Am Urban, Berlin
Hosp. Abente E Lago, A Coruña
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia Presidio Spedali Civili, Brescia
Centre Hospitalier de Novillars, Novillars
Hosp. Gral. Univ. Gregorio Maranon, Madrid
Csm Miraflores, Alcobendas
Csm Arganda Del Rey, Arganda
Hopital la Colombiere, Montpellier
Centre Hospitalier Guillaume Regnier, Rennes
Azienda Sanitaria Alto Adige, Bolzano
Cabinet medical, Dax
Usmc Carmona, Carmona
Usmc Mairena Del Aljarafe, Mairena del Aljarafe
Hosp. Clinico Univ. de Valencia, Valencia
Csm Rondilla, Valladolid
Hosp. Univ. Miguel Servet, Zaragoza
CH de Jury, Metz
SPDC Asltaranto, Statte
NPZR - Neuropsychatrisches Zentrum Riem, München
CH Montauban, Montauban
Hopital Sainte Musse, Toulon
Kbo-Inn-Salzach-Klinikum GmbH, Wasserburg A. Inn
Centro Igiene Mentale ASL Salerno, Oliveto Citra
Centre Hospitalier Esquirol, Limoges
Centre Médico Psychologique De Courbevoie, Asnières-sur-Seine
Casa di Cura Villa Von Siebenthal, Genzano di Roma
Birmingham & Solihull MH NHS FT, Birmingham
Leicester Partnership NHS Trust, Leicester
West London Mental Health Trust, London
Lead Sponsor
Janssen-Cilag International NV
INDUSTRY